How confident are pharmacists in providing pharmaceutical care on anticoagulants? A cross-sectional, self-administered questionnaire study in Borneo, Malaysia

References

• Alquwaizani M, Buckley L, Adams C, Fanikos J. Anticoagulants: a review of the pharmacology, dosing, and complications. Curr Emerg Hosp Med Rep. 2013. https://doi.org/10.1007/s40138-013-0014-6.
   PubMedGoogle Scholar
• Barnes GD, Lucas E, Alexander GC, Goldberger ZD. National trends in ambulatory oral anticoagulant use. Am J Med. 2015. https://doi.org/10.1016/j.amjmed.2015.05.044.
   PubMed Web of Science ®Google Scholar
• Roderick P. Epidemiology of venous thromboembolism. Clin Risk. 1997. https://doi.org/10.1177/135626229700300301.
   Google Scholar
• Lee LH, Gallus A, Jindal R, Wang C, Wu CC. Incidence of venous thromboembolism in Asian populations: a systematic review. Thromb Haemost. 2017. https://doi.org/10.1160/TH17-02-0134.
   Web of Science ®Google Scholar
• Lim CW, Kasim S, Ismail JR, Yul N, Chua C, Khir RN, et al. Prevalence of atrial fibrillation in the Malaysian communities. Heart Asia. 2016. https://doi.org/10.1136/heartasia-2016-010775.
   Google Scholar
• Lip GYH, Nieuwlaat R, Pisters R, Lane DA, Crijns HJGM, Andresen D, et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation. Chest. 2010. https://doi.org/10.1378/chest.09-1584.
   Web of Science ®Google Scholar
• January CT, Wann LS, Calkins H, Chen LY, Cigarroa JE, Cleveland JC, et al. AHA/ACC/HRS FOCUSED UPDATE of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart R. Circulation. 2019. https://doi.org/10.1161/CIR.0000000000000665.
   PubMedGoogle Scholar
• Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, et al. ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2020. https://doi.org/10.1093/eurheartj/ehaa612.
   Google Scholar
• Mazzolai L, Aboyans V, Ageno W, Agnelli G, Alatri A, Bauersachs R, et al. Diagnosis and management of acute deep vein thrombosis: a joint consensus document from the European Society of Cardiology working groups of aorta and peripheral vascular diseases and pulmonary circulation and right ventricular function. Eur Heart J. 2018. https://doi.org/10.1093/eurheartj/ehx003.
   Web of Science ®Google Scholar
• Schünemann HJ, Cushman M, Burnett AE, Kahn SR, Beyer-Westendorf J, Spencer FA, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients. Blood Adv. 2018. https://doi.org/10.1182/bloodadvances.2018022954.
   Web of Science ®Google Scholar
• Kearon C, Elie A, Akl JO, Blaivas A, Jimenez D, Bounameaux H, Huisman M, et al. Antithrombotic therapy for VTE disease: CHEST Guideline. Chest. 2016. https://doi.org/10.1016/j.chest.2015.11.026.
   PubMed Web of Science ®Google Scholar
• Ministry of health of Malaysia. Clinical practice guideline venous thromboembolism prevention and treatment of. vol. 13. 2017.
   Google Scholar
• Aziz ZA, Sidek NN, Kamarudin MK, Baharum N, Muneer A, Hamid A, et al. Annual report of the Malaysian Stroke Registry. 2016.
   Google Scholar
• Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007. https://doi.org/10.7326/0003-4819-146-12-200706190-00007.
   Web of Science ®Google Scholar
• Kirchhof P, Uk C, Uk DK, Uk BC, Germany HD, Heidbuchel H, et al. ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS The Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the Europe. Eur Heart J. 2016. https://doi.org/10.1093/eurheartj/ehw210.
   Web of Science ®Google Scholar
• Mismetti P, Schellong S, Eriksson H, Baanstra D, Sc M, Schnee J, et al. Dabigatran versus warfarin in the treatment of acute venous thromboembolism. N Engl J Med. 2009. https://doi.org/10.1056/NEJMoa0906598.
   PubMed Web of Science ®Google Scholar
• Hacke W, Ph D, Breithardt G, Halperin JL, Hankey GJ, Piccini JP, et al. Rivaroxiban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011. https://doi.org/10.1056/NEJMoa1009638.
   PubMedGoogle Scholar
• Hylek EM, Hanna M, Al-khalidi HR, Ph D, Ansell J, Atar D, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011. https://doi.org/10.1056/NEJMoa1107039.
   PubMed Web of Science ®Google Scholar
• Gallus AS, Johnson M, Masiukiewicz U, Pak R, Ph D, Thompson J, et al. Oral apixaban for the treatment of acute venous thromboembolism. N Engl J Med. 2013. https://doi.org/10.1056/NEJMoa1302507.
   Web of Science ®Google Scholar
• Investigators TH. Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism. N Engl J Med. 2013. https://doi.org/10.1056/NEJMoa1306638.
   Web of Science ®Google Scholar
• Eikelboom J, Oldgren J, Ph D, Parekh A, Pogue J, Sc M, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009. https://doi.org/10.1056/NEJMoa0905561.
   PubMedGoogle Scholar
• Scott D, Brenner B, Buller HR, Gallus AS, Anthonie W, Misselwitz F, et al. Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med. 2010. https://doi.org/10.1056/NEJMoa1007903.
   Web of Science ®Google Scholar
• Pharmaceutical Services Programme Ministry of Health Malaysia. Malaysian Statistics on Medicines. 2016.
   Google Scholar
• Ministry of health of Malaysia. Anticoagulation MTAC (AC-MTAC) protocol 2nd edition (2020). vol. 2. 2020.
   Google Scholar
• Leblanc K, Semchuk WM. A pharmacist checklist for direct oral anticoagulant management: raising the bar. Can Pharm J. 2018. https://doi.org/10.1177/1715163518756926.
   Web of Science ®Google Scholar
• Ashjian E, Pharm D, Kurtz B, Pharm D, Renner E, Pharm D, et al. Evaluation of a pharmacist-led outpatient direct oral anticoagulant service. Am J Health Pharm. 2017. https://doi.org/10.2146/ajhp151026.
   PubMed Web of Science ®Google Scholar
• Manzoor BS, Cheng W, Lee JC, Uppuluri EM, Edith A. Quality of pharmacist-managed anticoagulation therapy in long-term ambulatory settings: a systematic review. Ann Pharmacother. 2017. https://doi.org/10.1177/1060028017721241.
   PubMed Web of Science ®Google Scholar
• Papastergiou J, Kheir N, Ladova K, Rydant S. Pharmacists’ confidence when providing pharmaceutical care on anticoagulants, a multinational survey. Int J Clin Pharm. 2017. https://doi.org/10.1007/s11096-017-0551-2.
   PubMed Web of Science ®Google Scholar
• Hamedi N, da Costa FA, Horne R, Levitan M, Begley A, Antoniou S. How prepared are pharmacists to support atrial fibrillation patients in adhering to newly prescribed oral anticoagulants? Int J Clin Pharm. 2017. https://doi.org/10.1007/s11096-017-0529-0.
   PubMed Web of Science ®Google Scholar
• Ministry of health of Malaysia. Ministry of Health. Ministry of Health Medicines Formulary (MOHMF) 2018:1–346. https://www.pharmacy.gov.my/v2/sites/default/files/document-upload/fukkm-1-2020_0.pdf.
   Google Scholar
• Naing L, Winn T, Rusli BN. Practical issues in calculating the sample size for prevalence studies. Arch Orofac Sci. 2006;1:9–14.
   Google Scholar
• Lindsey C, Sheather S. GVSELECT: Stata module to perform best subsets variable selection, Statistical Software Components S457816. Boston College Department of Economics. 2014.
   Google Scholar
• Ministry of Health Malaysia. Record of Training and Experience of provisionally registered pharmacist (PRP) - Community Pharmacy. 2017.
   Google Scholar
• Nutescu EA, Shapiro NL, Ibrahim S, West P. Warfarin and its interactions with foods, herbs and other dietary supplements. Expert Opin Drug Saf. 2006. https://doi.org/10.1517/14740338.5.3.433.
   PubMed Web of Science ®Google Scholar